Biogen Inc
Here’s a rapid-fire update on all 35 stocks in the Club’s portfolio, including a new buy
Jim Cramer ran through all 35 Club stocks during our September Monthly Meeting on Thursday. Source
Read More
Sage Therapeutics stock plunges more than 50% after FDA denies wider use of postpartum depression drug
In this photo illustration, the Sage Therapeutics logo of a biopharmaceutical company seen on a smartphone and on a pc screen. Pavlo Gonchar | SOPA Images | Lightrocket | Getty Images Shares of Sage Therapeutics fell more than 50% on Monday after the Food and Drug Administration approved the biotech company’s oral drug zuranolone for […]
Read More
This defense contractor and automaker are between the most oversold S&P 500 stocks
Right after selling off far more than 9% this 7 days, shares of defense contractor RTX glance poised for a bounce back, according to just one specialized indicator. The S & P 500 attained this 7 days following the Federal Reserve instituted a 25 foundation level hike , bringing interest rates to their optimum amount […]
Read More
These health-care companies see opportunity ahead from Alzheimer’s drug approval
As patients with Alzheimer’s disease seek out a newly approved treatment, they will need MRIs, blood tests and other diagnostics, fueling increased demand for these important tools. In earnings calls this week, both GE Healthcare and Quest Diagnostics made references to the potential opportunity here, although neither company put any specific estimates behind their comments. […]
Read More
Stocks making the biggest moves premarket: Intel, Roku, Procter & Gamble and more
In this article PG ROKU INTC Follow your favorite stocksCREATE FREE ACCOUNT Signage outside Intel headquarters in Santa Clara, California, on Monday, Jan. 30, 2023. David Paul Morris | Bloomberg | Getty Images Check out the companies making headlines before the bell. Intel — Shares popped 6.7% after the chipmaker posted better-than-expected second-quarter results and […]
Read More
Stocks making the biggest moves midday: Spotify, RTX, General Electric and more
In this article ALK A PKG NXPI SPOT MMM Follow your favorite stocksCREATE FREE ACCOUNT Jonathan Raa | Nurphoto | Getty Images Check out the companies making headlines in midday trading. 3M – Shares of the chemical manufacturer rose 5.5% following the company’s latest earnings report. 3M posted $7.99 billion in revenue, beating analysts’ estimates […]
Read More
Biogen to cut 1,000 jobs to save costs as company prepares for Leqembi launch
A Biogen facility in Cambridge, Massachusetts. Brian Snyder | Reuters Biogen on Tuesday said it expects to cut approximately 1,000 jobs, or about 11% of its workforce, to save costs as the biotech company prepares to launch its newly approved Alzheimer’s drug Leqembi. It’s the latest round of layoffs after Biogen slashed nearly 900 jobs […]
Read More
Eli Lilly expects FDA decision on Alzheimer’s treatment donanemab by the end of the year
Eli Lilly and Company, Pharmaceutical company headquarters in Alcobendas, Madrid, Spain. Cristina Arias | Cover | Getty Images Eli Lilly on Monday said it applied for full U.S. Food and Drug Administration approval of its Alzheimer’s treatment, donanemab, and expects the agency to make a decision by the end of the year. Eli Lilly is […]
Read More
Medicare will pay for Alzheimer’s drug Leqembi. What patients and doctors should know
The Alzheimer’s drug Leqembi is seen in this undated handout image obtained by Reuters on January 20, 2023. Eisai | via Reuters Medicare has agreed to pay for the Alzheimer’s treatment Leqembi, a major turning point for patients who are diagnosed with the early stages of the disease. Leqembi is the only drug on the […]
Read More